Search

Your search keyword '"Staubach, Petra"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Staubach, Petra" Remove constraint Author: "Staubach, Petra" Database Unpaywall Remove constraint Database: Unpaywall
174 results on '"Staubach, Petra"'

Search Results

1. Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa

5. The socio‐economic burden of H1‐antihistamine‐refractory chronic spontaneous urticaria in Germany

6. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries

8. Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results from CURE

9. Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany

10. Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study

11. Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment

12. Garadacimab for the prevention of hereditary angioedema attacks: a plain language summary of the VANGUARD study

14. A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectiveness

15. Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial

16. Drivers of disease severity and burden of hidradenitis suppurativa: a cross‐sectional analysis on 553 German patients

17. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

18. Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey

19. EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS: RESULTS FROM DISCREET, A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

20. Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern

21. Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment

22. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative

23. Characterization of patients with psoriatic arthritis in dermatologic and rheumatologic care: analysis of two registries

24. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial

27. In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria

29. The clinical features of persons suffering from acne inversa

30. A centre-based, ambulatory care concept for Hidradenitis suppurativa improves disease activity, burden, and patient satisfaction: results from the randomised controlled trial EsmAiL

31. Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

32. Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-blind DISCREET Study

34. Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product

35. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results

36. Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial

37. Efficacy and Safety of Subcutaneous Garadacimab for the Prophylaxis of Hereditary Angioedema Attacks in Adults and Adolescent Patients with HAE: Results from a Multicenter, Placebo-Controlled Phase 3 Trial

39. Garadacimab, a Factor XIIa Inhibitor for Hereditary Angioedema Prevention (VANGUARD Study)

42. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU , a UCARE study

43. Multidisziplinarität als Schlüssel zum Erfolg

44. Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde

45. Generalized pustular psoriasis: overview of the status quo and results of a panel discussion

48. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG-CU, a UCARE Study

Catalog

Books, media, physical & digital resources